✦ LIBER ✦

The role of antinuclear autoantibodies in patients with psoriasis treated with anti–tumor necrosis factor-alpha agents: A retrospective long-term study

✍ Scribed by Rosita Saraceno; Francesca Specchio; Tiago Torres; Steven Paul Nisticò; Stefano Rizza; Sergio Chimenti

Book ID: 116588117
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 369 KB
Volume: 66
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2011.06.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.1.173: FORMATION OF NON-ORGAN SPECIFIC

P.1.173: FORMATION OF NON-ORGAN SPECIFIC AUTOANTIBODIES (NOSA) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) TREATED WITH ANTI-TUMOR NECROSIS FACTOR-ALPHA AGENTS

✍ I. Bravatà; M. Cappello; C. Randazzo; A. Licata; F. Barbaria; P.L. Almasio; A. C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Tight control is important in patients w

Tight control is important in patients with rheumatoid arthritis treated with an anti-tumor necrosis factor biological agent: prospective study of 91 cases who used a biological agent for more than 1

✍ Hiroshige Sano; Katsumitsu Arai; Takehiro Murai; Junichi Fujisawa; Naoki Kondo; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 181 KB

Long Term Costs and Outcomes in Psoriati

Long Term Costs and Outcomes in Psoriatic Arthritis Patients Not Responding to Conventional Therapy Treated with Tumor Necrosis Factor Inhibitors: The Extension of Psoriatic Arthritis Cost Evaluation (PACE) Study

✍ Cortesi, P.A.; Olivieri, I.; de Portu, S.; Salvarani, C.; Cauli, A.; Lubrano, E. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

The risk of serious infection in patient

The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database

✍ Sakai, Ryoko; Cho, Soo-Kyung; Nanki, Toshihiro; Koike, Ryuji; Watanabe, Kaori; Y 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 250 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, phase III study of the human anti-tumor necrosis factor antibody adalimumab administered as subcutaneous injections in Korean rheumatoid arthritis patients treated with methotrexate

✍ KIM, Ho-Youn ;LEE, Soo-Kon ;SONG, Yeong Wook ;YOO, Dae-Hyun ;KOH, Eun-Mi ;YOO, B 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Does cancer that occurs during or after

Does cancer that occurs during or after anti–tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents

✍ Pauline Raaschou; Julia F. Simard; Martin Neovius; Johan Askling; Anti-Rheumatic 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 2 views